Results
CHAQ DI at the baseline was 0,541, at the end of follow up 0,398 (p<0,05). Number of patients with moderate/ severe disability decreased from 29 to 18 (33,3% vs. 20,7%, p<0,01). Number of patients in remission increased from 15 to 47 (17,2% vs.54,0%, p<0,001). Seventy (80,6%)pts. with normal CHAQ DI at baseline, were in remission at the end of study, while 66 (75,9%) pts. with moderate/severe CHAQ DI at the beginning had active disease at the last visit. CHAQ showed good predictive ability for the disease outcome (71,3%). Odds ratio for having active disease for patients with mild CHAQ DI was high (OR 3, 33, CI=1, 746, p=0, 044) , for patients with moderate/severe CHAQ DI was very high (OR 13, 095, CI=3, 882, p<0, 001) , compared to patients with normal CHAQ value. Patients with moderate/severe CHAQ DI had hazard ratio for the active disease 4,959 (CI=1, 855-11,385, p<0,001) .
Conclusion
CHAQ demonstrated good ability in predicting outcome of the disease. Due to its simplicity and accessibility it is useful in everyday clinical practice for identifying patients with poor prognosis.
